Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Hematological Disorders in Human Patients with Son Mutations

Lana Vukadin, Jung-Hyun Kim, PhD, Tara Bly Hackwelder, Nathan Ungerleider, PhD, Erik Flemington, Eun-Young Erin Ahn, PhD

Blood (2019) 134 (Supplement_1): 3709.

https://doi.org/10.1182/blood-2019-130616

Published: 2019

Journal Articles

Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma

Namrata Singh, MD, Sarah L Mott, Ashley Noel McCarthy, MPH, Sergei Syrbu, MD PhD, Thomas M. Habermann, MD, Andrew L. Feldman, MD, Susan L Slager, PhD, Grzegorz Nowakowski, MD, Thomas E. Witzig, MD, Umar Farooq, MD, James R. Cerhan, MD PhD, Zuhair Ballas, Brian K. Link, MD

Blood (2019) 134 (Supplement_1): 1604.

https://doi.org/10.1182/blood-2019-122737

Published: 2019

Journal Articles

Somatic Mutations in T Cells As Possible Regulators of Immunodeficiency

Paula Savola, MD, Timi Martelius, MD PhD, Matti Kankainen, PhD, Yrjö Koski, BTech, Samuli Eldfors, PhD, Jani Huuhtanen, BMed, Tiina Kelkka, PhD, Sofie Lundgren, BMed, Pekka Ellonen, BSc, Panu Kovanen, MD PhD, Soili Kytölä, PhD, Mikko Seppänen, MD PhD, Satu Mustjoki, MD PhD

Blood (2018) 132 (Supplement 1): 515.

https://doi.org/10.1182/blood-2018-99-110757

Published: 2018

Journal Articles

Identifying Possible Candidate Factors Influencing the Penetrance of Heterozygous NFKB1 Loss of Function Mutations By Whole Exome Sequencing

Cyrill Schipp, MSc, Arndt Borkhardt, MD, Polina Stepensky, MD, Ute Fischer, PhD

Blood (2016) 128 (22): 3706.

https://doi.org/10.1182/blood.V128.22.3706.3706

Published: 2016

Journal Articles

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Kieron Dunleavy, MD, Benjamin L.W. Reiter, Cliona M. Grant, MD, Margaret Shovlin, RN, George W. Wright, Thomas A. Fleisher, MD, Wyndham H. Wilson, MD, PhD

Blood (2010) 116 (21): 2881.

https://doi.org/10.1182/blood.V116.21.2881.2881

Published: 2010

Journal Articles

IgA and IgG Hypogammaglobulinemia Does Not Predict for Recurrent Infection Risk and Persists Despite Therapeutic Response in Patients with Waldentrom's Macroglobulinemia.

Zachary Hunter, Robert Manning, Christina Hanzis, Bryan Ciccarelli, Thea Ioakimidis, MS, Christopher J Patterson, Megan Lewicki, Hsuiyi Tseng, Ping Gong, Xia Liu, MD, Yangsheng Zhou, MD, PhD, Guang Yang, PhD, Jenny Sun, MD, Lian Xu, Patricia Sheehy, NP, Massimo Morra, MD, Steven Treon, MD, PhD

Blood (2009) 114 (22): 1947.

https://doi.org/10.1182/blood.V114.22.1947.1947

Published: 2009

Journal Articles

Hypogammaglobulinemia Following Rituximab and High-Dose Therapy and Autologous Stem-Cell Transplant: Incidence and Predictors of Prolonged Immunoglobulin Deficiencies

Nancy Pennell, Matthew Cheung, MD SM, FRCP, Lisa K Hicks, MD, MSc, Rena Buckstein, MD, FRCPC, Kevin R Imrie, MD, Eugenia Piliotis, MD, David Spaner, Zeina Ghorab, Marciano D. Reis, MD, Violet Milliken, Angela Boudreau, Neil Berinstein, MD

Blood (2008) 112 (11): 4351.

https://doi.org/10.1182/blood.V112.11.4351.4351

Published: 2008

Journal Articles

B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.

Seah H. Lim, MD, PhD, William V. Esler, MD, Yana Zhang, MD. PhD, Jian Zhang, BS, Phillip O. Periman, MD, Colleen Burris, RN, OCN, Mary Townsend, MD

Blood (2007) 110 (11): 4480.

https://doi.org/10.1182/blood.V110.11.4480.4480

Published: 2007

Journal Articles

Characteristics of Immunoglobulin Deficiency in Patients with Untreated Multiple Myeloma Stage II and III.

Markus Hamel, MD, Wolfram Poenisch, MD, Dirk Hasenclever, PhD, Goetz Gelbrich, PhD, Markus Loeffler, MD, Haifa K. Al Ali, MD, Stefanie Lehmann, Dietger Niederwieser, MD, Karlheinz Merkle, MD

Blood (2004) 104 (11): 4861.

https://doi.org/10.1182/blood.V104.11.4861.4861

Published: 2004

Journal Articles

Maintenance Rituximab after Autologous Stem Cell Transplant for High-Risk B-Cell Lymphoma Induces Prolonged and Severe Hypogammaglobulinemia.

Seah H. Lim, MD, PhD, Yana Zhang, MD, PhD, Zhiqing Wang, PhD, William V. Esler, MD, David Beggs, MD, Brian Pruitt, MD, Paul Hancock, MD, Mary Townsend, MD

Blood (2004) 104 (11): 1408.

https://doi.org/10.1182/blood.V104.11.1408.1408

Published: 2004

NARROW

Hematological Disorders in Human Patients with Son Mutations

Prevalence and the Impact of Hypogammaglobulinemia in Newly Diagnosed, Untreated Diffuse Large B Cell Lymphoma

Somatic Mutations in T Cells As Possible Regulators of Immunodeficiency

Identifying Possible Candidate Factors Influencing the Penetrance of Heterozygous NFKB1 Loss of Function Mutations By Whole Exome Sequencing

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

IgA and IgG Hypogammaglobulinemia Does Not Predict for Recurrent Infection Risk and Persists Despite Therapeutic Response in Patients with Waldentrom's Macroglobulinemia.

Hypogammaglobulinemia Following Rituximab and High-Dose Therapy and Autologous Stem-Cell Transplant: Incidence and Predictors of Prolonged Immunoglobulin Deficiencies

B-Cell Depletion for Two Years after Autologous Stem Cell Transplant Reduces Lymphoma Relapse but Induces Prolonged Hypogammaglobulinemia beyond the Rituxan Maintenance Period.

Characteristics of Immunoglobulin Deficiency in Patients with Untreated Multiple Myeloma Stage II and III.

Maintenance Rituximab after Autologous Stem Cell Transplant for High-Risk B-Cell Lymphoma Induces Prolonged and Severe Hypogammaglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only